Influence of gender on receipt of guideline-based antiretroviral therapy in the era of HAART

Jennifer M. Cocohoba Department of Clinical Pharmacy, School of Pharmacy, University of California, San Francisco, CA, USACorrespondence[email protected]

Keri N. Althoff Department of Epidemiology, John Hopkins Bloomberg School of Public Health, John Hopkins University, Baltimore, MD, USA

Rebecca Godfrey Department of Molecular Microbiology and Immunology, John Hopkins Bloomberg School of Public Health, John Hopkins University, Baltimore, MD, USA

Frank J. Palella Infectious Diseases Division, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA

Ruth M. Greenblatt Department of Clinical Pharmacy, School of Pharmacy, University of California, San Francisco, CA, USA; Departments of Medicine, Epidemiology and Biostatistics, School of Medicine, University of California, San Francisco, CA, USA

Influence of gender on receipt of guideline-based antiretroviral therapy in the era of HAART

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Influence of gender on receipt of guideline-based antiretroviral therapy in the era of HAART

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date